Loveland-Jones C, Gaughan J, Caudle A, Murphy B, et al. Evaluation of traditional targeted axillary dissection eligibility criteria for node-positive breast cancer after neoadjuvant chemotherapy in a prospective multicenter registry. Eur J Surg Oncol 2024;50:108245.
PMID: 38484493